BTG plc: Notification of Results
London, UK, 25 October 2013: BTG plc (LSE: BTG), the specialist healthcare company, will be announcing its interim results for the six months ended 30 September 2013 on Tuesday 12 November 2013.
An analyst presentation will take place at 9.30am at the offices of FTI Consulting, Holborn Gate, 26 Southampton Buildings, London WC2A 1PB.
Andy Burrows, Director of Investor Relations
+44 (0)20 7575 1741
Ben Atwell/Mo Noonan
+44 (0)20 7831 3113
BTG is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and varicose veins. The company has diversified revenues from sales of its own marketed products and from royalties on partnered products, and is seeking to acquire new programmes and products to develop and market to specialist physicians.